🇺🇸 FDA
Patent

US 9217010

N-substituted indenoisoquinolines and syntheses thereof

granted A61KA61K31/473A61K31/4741

Quick answer

US patent 9217010 (N-substituted indenoisoquinolines and syntheses thereof) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/473, A61K31/4741, A61P, A61P35/00